Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
YANCHANG PETRO
00346
CN Stock MarketDetailed Quotes
Zhejiang Tianyu Pharmaceutical (300702)
- 22.53
- -0.40-1.74%
Market Closed Apr 17 15:00 CST
7.84BMarket Cap40.89P/E (TTM)
22.90High22.36Low25.87KlotVolume22.80Open22.93Prev Close58.31MTurnover1.23%Turnover Ratio139.94P/E (Static)347.98MShares31.2052wk High2.11P/B4.76BFloat Cap19.3352wk Low27.52Limit Up211.16MShs Float71.54Historical High18.34Limit Down2.36%Range %6.67Historical Low0.05Dividend TTM22.54Avg Price15.21KlotAsk0.22%Div Yield TTM100Lot Size10.03KlotBid
Zhejiang Tianyu Pharmaceutical (300702) Income Statement
All
YOY
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 18.36%2.29B | 23.87%1.57B | 10.13%759.32M | 4.10%2.63B | 3.61%1.93B | -6.01%1.27B | -11.29%689.45M | -5.23%2.53B | -10.53%1.86B | -8.65%1.35B |
| Operating revenue | 18.36%2.29B | 23.87%1.57B | 10.13%759.32M | 4.10%2.63B | 3.61%1.93B | -6.01%1.27B | -11.29%689.45M | -5.23%2.53B | -10.53%1.86B | -8.65%1.35B |
| Other operating revenue | ---- | 243.77%5.67M | ---- | 132.12%15.64M | ---- | 5.78%1.65M | ---- | -56.05%6.74M | ---- | -79.00%1.56M |
| Total operating cost | 11.58%1.99B | 16.92%1.35B | 7.75%647.73M | 9.57%2.5B | 10.88%1.79B | 0.38%1.15B | -8.13%601.12M | -13.85%2.28B | -18.73%1.61B | -15.05%1.15B |
| Operating cost | 11.64%1.39B | 18.49%968.13M | 6.62%475.43M | 11.83%1.72B | 11.51%1.25B | 0.74%817.04M | -6.33%445.9M | -22.33%1.54B | -26.91%1.12B | -23.47%811.08M |
| Operating tax surcharges | 26.22%22.58M | 19.43%15.07M | -21.22%5.16M | -24.19%25.14M | -9.50%17.89M | -3.55%12.62M | -8.98%6.56M | 84.39%33.17M | 94.20%19.77M | 141.27%13.08M |
| Operating expense | 31.66%118.27M | 30.12%70.19M | 35.05%33.01M | 52.30%148.93M | 46.77%89.83M | 30.57%53.94M | 84.97%24.44M | 106.19%97.79M | 81.65%61.21M | 113.79%41.31M |
| Administration expense | 10.19%257.2M | 9.79%167.52M | 0.59%77.27M | 7.08%353.51M | 10.90%233.41M | 0.39%152.58M | -10.32%76.82M | -12.94%330.13M | -23.33%210.46M | -15.52%151.98M |
| Financial expense | 30.88%24.29M | 2,267.40%11.21M | 228.25%3.4M | -69.98%10.91M | -10.75%18.56M | -105.62%-517.2K | -113.44%-2.65M | 462.92%36.34M | 165.17%20.79M | 151.77%9.21M |
| -Interest expense (Financial expense) | -18.00%33.51M | -16.18%22.61M | -20.55%11.31M | 8.34%54.07M | 16.01%40.86M | 16.94%26.98M | 20.65%14.23M | 47.45%49.91M | 51.04%35.22M | 58.54%23.07M |
| -Interest Income (Financial expense) | 66.23%-5.37M | 66.20%-4.56M | 83.74%-1.88M | -227.57%-19.88M | -236.45%-15.9M | -248.90%-13.5M | -571.42%-11.54M | 15.93%-6.07M | 13.24%-4.73M | -5.31%-3.87M |
| Research and development | -0.41%179.66M | -1.11%116.43M | 6.78%53.45M | -2.02%238.9M | -0.41%180.4M | -3.75%117.73M | -4.65%50.06M | 5.50%243.82M | 8.77%181.14M | 15.48%122.32M |
| Credit Impairment Loss | -859.66%-6.12M | -585.16%-15.11M | -25,125.30%-3.88M | 121.70%1.37M | 114.55%805.55K | 148.35%3.11M | 99.57%-15.39K | -262.67%-6.3M | -220.69%-5.54M | -164.30%-6.44M |
| Asset Impairment Loss | -163.37%-70.11M | -85.14%-57.06M | -46.37%-18.41M | 65.77%-48M | 68.46%-26.62M | 32.83%-30.82M | -127,504.58%-12.57M | -45.35%-140.22M | -2,426.25%-84.41M | -7,164.09%-45.88M |
| Other net revenue | -44.60%-55.97M | -34.07%-58.62M | 44.14%-15.89M | 72.22%-49.47M | 74.65%-38.71M | 54.47%-43.73M | -762.92%-28.45M | -43.97%-178.05M | -317.28%-152.69M | -1,260.88%-96.04M |
| Fair value change income | -97.50%377.1K | -96.76%444.06K | -95.29%295.3K | 247.25%14.77M | 131.58%15.1M | 133.73%13.71M | -46.80%6.28M | 66.50%-10.03M | 9.43%-47.82M | -22.74%-40.64M |
| Invest income | 99.54%-182.39K | 99.56%-169.83K | 98.11%-497.93K | 20.61%-41.81M | -18.89%-39.92M | -137.29%-38.58M | -196.64%-26.38M | -77.23%-52.66M | -486.88%-33.58M | -214.05%-16.26M |
| -Including: Investment income associates | 84.14%-419.14K | 79.32%-408.89K | 67.91%-255.47K | 15.13%-4.43M | 32.78%-2.64M | 15.53%-1.98M | 31.87%-796.08K | 20.18%-5.22M | -30.98%-3.93M | -211.64%-2.34M |
| Asset deal income | -4,715.94%-433.73K | -315,297.55%-125.02K | 19,842.36%8.38K | 2,544.62%718.55K | 89.56%-9.01K | -100.09%-39.64 | -99.84%42.04 | -18.44%-29.39K | -136.88%-86.23K | -82.12%41.81K |
| Other revenue | 71.79%20.5M | 51.27%13.39M | 55.26%6.59M | -24.69%23.49M | -36.37%11.93M | -32.62%8.85M | -14.26%4.25M | 9.06%31.19M | -8.32%18.75M | -10.21%13.14M |
| Operating profit | 122.43%237.15M | 134.70%160.26M | 59.80%95.7M | 19.97%84.87M | 5.78%106.62M | -32.64%68.28M | -52.91%59.89M | 169.47%70.75M | 55.01%100.79M | -11.32%101.37M |
| Add:Non operating Income | 84.64%2.67M | 109.76%1.84M | 780.09%863.27K | -78.23%1.33M | 484.58%1.44M | 443.42%877.12K | -7.53%98.09K | 225.44%6.1M | -50.37%247.06K | -35.92%161.41K |
| Less:Non operating expense | 260.83%4.82M | 348.88%2.48M | 1,027.15%637.52K | 53.32%7.56M | -68.06%1.34M | -85.75%552.2K | -95.14%56.56K | -53.22%4.93M | -15.48%4.18M | 25.49%3.87M |
| Total profit | 120.19%235M | 132.66%159.62M | 60.07%95.93M | 9.35%78.64M | 10.20%106.73M | -29.74%68.61M | -52.48%59.93M | 165.08%71.92M | 59.91%96.85M | -12.40%97.65M |
| Less:Income tax cost | -34.92%14.06M | -34.34%10.11M | -49.80%9.75M | -49.05%22.7M | -22.97%21.61M | -47.90%15.39M | -24.97%19.41M | 432.44%44.56M | 28.68%28.06M | 78.79%29.54M |
| Net profit | 159.57%220.93M | 180.96%149.51M | 112.71%86.18M | 104.45%55.94M | 23.72%85.11M | -21.87%53.22M | -59.58%40.52M | 123.02%27.36M | 77.47%68.8M | -28.26%68.11M |
| Net profit from continuing operation | 159.57%220.93M | 180.96%149.51M | 112.71%86.18M | 104.45%55.94M | 23.72%85.11M | -21.87%53.22M | -59.58%40.52M | 123.02%27.36M | 77.47%68.8M | -28.26%68.11M |
| Net profit of parent company owners | 159.57%220.93M | 180.96%149.51M | 112.71%86.18M | 104.45%55.94M | 23.72%85.11M | -21.87%53.22M | -59.58%40.52M | 123.02%27.36M | 77.47%68.8M | -28.26%68.11M |
| Earning per share | ||||||||||
| Basic earning per share | 162.50%0.63 | 186.67%0.43 | 112.80%0.2477 | 100.00%0.16 | 20.00%0.24 | -25.00%0.15 | -59.88%0.1164 | 123.53%0.08 | 81.82%0.2 | -25.93%0.2 |
| Diluted earning per share | 162.50%0.63 | 186.67%0.43 | 112.80%0.2477 | 100.00%0.16 | 20.00%0.24 | -25.00%0.15 | -59.88%0.1164 | 123.53%0.08 | 81.82%0.2 | -25.93%0.2 |
| Other composite income | 255.56%0.32 | 0.32 | -785,482,016.87%-6.52M | 0.09 | 0.83 | |||||
| Other composite income of parent company owners | 255.56%0.32 | --0.32 | ---- | -785,482,016.87%-6.52M | --0.09 | ---- | ---- | --0.83 | ---- | ---- |
| Total composite income | 159.57%220.93M | 180.96%149.51M | 112.71%86.18M | 80.62%49.42M | 23.72%85.11M | -21.87%53.22M | -59.58%40.52M | 123.02%27.36M | 77.47%68.8M | -28.26%68.11M |
| Total composite income of parent company owners | 159.57%220.93M | 180.96%149.51M | 112.71%86.18M | 80.62%49.42M | 23.72%85.11M | -21.87%53.22M | -59.58%40.52M | 123.02%27.36M | 77.47%68.8M | -28.26%68.11M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! Iran's foreign minister, in accordance with the Lebanon ceasefire agreement, announced
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm